1.Vikram, HR, Quagliarello, VJ. Diagnosis and management of empyema. Curr Clin Top Infect Dis 2002; 22:196–213.
2.Iwahara, T, Ichiyama, S, Nada, T, Shimokata, K, Nakashima, N. Clinical and epidemiologic investigations of nosocomial pulmonary infections caused by methicillin-resistant Staphylococcus aureus. Chest 1994; 105: 826–831.
3.Tenover, FC, Arbeit, RD, Goering, RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33:2233–2239.
4.NCCLS. Performance standards for antimicrobial disk susceptibility tests. 6th ed.; approved standard. NCCLS document M2-A6. Wayne, PA: NCCLS; 1997.
5.Garner, JS, Jarvis, WR, Emori, TG, Horan, TC, Hughes, JM. CDC definitions for nosocomial infections. In: Olmsted, RN, ed. APIC Infection control and Applied Epidemiology: Principles and Practice. St Louis: Mosby; 1996: A1–A20.
6.Maki, DG, Stolz, SM, Wheeler, S, Mermel, LA. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter: a randomized, controlled trial. Ann Intern Med 1997; 127:257–266.
7.Sampath, LA, Chowdhury, N, Caraos, L, Modak, SM. Infection resistance of surface modified catheters with either short-lived or prolonged activity. J Hosp Infect 1995; 30:201–210.
8.Nabulsi, N, Hanna, HA, Raad, II. Devices impregnated with novel antiseptic agents: broad-spectrum activity and prolonged antimicrobial durability. In: Program and Abstracts of the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (Chicago). Washington, DC: American Society for Microbiology; 2001:434. Abstract K-1459.
9.Chambers, HF. The changing epidemiology of Staphylococcus aureus? Emerg Infect Dis 2001; 7:178–182.
10.Kondo, D, Kita, Y. A successful case report of conservative treatment of MRSA empyema after right pneumonectomy. Kyobu Geka 1995; 48:592–594.